Appili Therapeutics Ratios and Metrics

Market cap in millions CAD. Fiscal year is April - March.

Millions CAD. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2017 - 2020
Period Ending	Jun '25 Jun 30, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	2017 - 2020
Market Capitalization	2	4	4	5	9	70	Upgrade
Market Cap Growth	-	-	-12.50%	-43.28%	-87.73%	120.84%	Upgrade
Enterprise Value	13	15	12	9	2	50	Upgrade
Last Close Price	0.01	0.04	0.04	0.04	0.12	1.11	Upgrade
Forward PE	-	-	-	-	-	3.27	Upgrade
PS Ratio	18.11	42.26	5.13	14.52	6.15	-	Upgrade
PB Ratio	-0.14	-0.32	-0.39	-0.66	-2.61	5.46	Upgrade
P/TBV Ratio	-	-	-	-	-	5.46	Upgrade
P/FCF Ratio	2.10	4.90	-	-	-	-	Upgrade
P/OCF Ratio	2.09	4.89	-	-	-	-	Upgrade
EV/Sales Ratio	128.28	152.75	14.08	26.53	1.57	-	Upgrade
EV/FCF Ratio	14.87	17.71	-	-	-	-	Upgrade
Debt / Equity Ratio	-0.92	-0.92	-0.75	-1.04	-1.52	0.08	Upgrade
Debt / FCF Ratio	14.19	14.19	-	-	-	-	Upgrade
Asset Turnover	0.04	0.04	0.36	0.06	0.11	-	Upgrade
Quick Ratio	0.19	0.19	0.11	0.97	1.21	3.86	Upgrade
Current Ratio	0.19	0.19	0.13	1.05	1.24	3.96	Upgrade
Return on Equity (ROE)	-	-	-	-	-529.79%	-132.65%	Upgrade
Return on Assets (ROA)	-278.71%	-278.71%	-217.68%	-86.67%	-115.98%	-66.38%	Upgrade
Return on Capital (ROIC)	-	-	-	-500.52%	-199.10%	-82.82%	Upgrade
Earnings Yield	-144.29%	-61.84%	-89.08%	-190.55%	-293.71%	-20.56%	Upgrade
FCF Yield	47.63%	20.41%	-58.76%	-208.24%	-223.12%	-16.45%	Upgrade
Buyback Yield / Dilution	-	-	-6.63%	-70.43%	-12.76%	-72.40%	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.